Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial membrane components and potassium channels represent a diverse class of targets essential for bacterial viability and bioenergetics. The bacterial cytoplasmic membrane, primarily composed of phospholipids such as phosphatidylglycerol, serves as a scaffold for critical proteins, including ion channels like KcsA that regulate potassium (K+) homeostasis (Doyle et al., 1998, Science). Antimicrobial agents targeting these structures typically function by disrupting membrane integrity or forming pores, leading to a rapid loss of membrane potential and the efflux of intracellular ions. For example, the lipopeptide daptomycin aggregates in the membrane to create ion-conducting pathways (Steenbergen et al., 2005, Journal of Antimicrobial Chemotherapy), while polymyxins interact with lipopolysaccharides to destabilize the outer membrane of Gram-negative bacteria (Landman et al., 2008, Clinical Microbiology Reviews). These mechanisms are particularly effective against multi-drug resistant pathogens, although therapeutic use is often constrained by potential toxicities, such as nephrotoxicity or myopathy, arising from interactions with host cell membranes or related human ion channels (Falagas & Kasiakou, 2006, Critical Care). Furthermore, bacterial potassium channels are frequently utilized as structural models in pharmacological research to design selective inhibitors, though few clinical drugs currently target them as their primary mechanism (Kuai et al., 2014, Nature Communications).
Disruption of bacterial membrane integrity and/or formation of ion-permeable pores leading to rapid depolarization and potassium efflux (Steenbergen et al., 2005).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial membrane components and potassium channels.